Nonalcoholic Steatohepatitis (NASH) Market Forecasted to Flourish with a Projected CAGR of 49.2% by 2030
Market Overview Nonalcoholic Steatohepatitis (NASH) is a liver condition characterized by inflammation and damage similar to that caused by alcohol abuse, but in individuals who consume little or no alcohol. The NASH market is witnessing significant growth due to the rising prevalence of obesity and metabolic disorders. It poses a substantial burden on healthcare systems globally, making it a key area of focus for research and development. Key Takeaways The NASH market is experiencing substantial growth driven by the increasing global prevalence of obesity and metabolic disorders. Diagnostic tools and imaging techniques are playing a crucial role in the early…
- Date: March 12, 2024
- Author: Timmy Thomas
- Category: PharmiWeb